On August 8, MariMed, Inc. (OTC:MRMD) delivered second quarter 2022 financial results near the beginning of U.S. cannabis earnings season. While industry results have generally been lackluster across the board, MariMed’s post-earnings conference call did reveal that future revenue prospects have plenty of upside potential for material expansion, simply by utilizing its existing footprint.
The revelation came courtesy of MariMed Co-Founder and Chief Administration Officer, Jon Levine. Speaking on the topline growth potential of the company, investors received a glimpse of just how much latent revenue generating capability MariMed’s footprint can produce once existing assets are ramped operationally, and in addition to the build out of their asset base to the maximum allowable by law. Jon Levine:
